Vanguard Capital Wealth Advisors - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vanguard Capital Wealth Advisors ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$218,774
-27.5%
6,135
-17.5%
0.20%
-43.0%
Q4 2022$301,564
+3.3%
7,435
-15.8%
0.35%
-1.7%
Q3 2022$292,000
-9.0%
8,835
-3.3%
0.36%
-2.2%
Q2 2022$321,000
-24.3%
9,135
-1.1%
0.36%
+19.8%
Q1 2022$424,000
-36.3%
9,235
-8.1%
0.30%
-36.7%
Q4 2021$666,000
-2.1%
10,049
-7.8%
0.48%
+5.0%
Q3 2021$680,000
-23.9%
10,899
+0.9%
0.46%
-32.7%
Q2 2021$894,000
-99.9%
10,799
-2.7%
0.68%
+13.2%
Q1 2021$703,565,000
+74115.7%
11,099
-9.4%
0.60%
-31.3%
Q4 2020$948,000
+57.5%
12,249
-12.2%
0.87%
+24.2%
Q2 2020$602,000
-52.3%
13,949
-29.8%
0.70%
-46.8%
Q4 2019$1,261,000
+105.0%
19,884
-9.0%
1.32%
+84.0%
Q3 2019$615,000
-1.4%
21,859
-7.2%
0.72%
-5.0%
Q2 2019$624,000
+33.0%
23,559
-7.9%
0.76%
+28.2%
Q1 2019$469,000
+47.9%
25,5840.0%0.59%
+24.8%
Q4 2018$317,000
-37.7%
25,584
-3.8%
0.47%
-18.8%
Q3 2018$509,000
+23.8%
26,584
-12.2%
0.58%
+6.4%
Q2 2018$411,000
-99.8%
30,284
-4.7%
0.55%
+94.3%
Q1 2018$213,588,000
+79.8%
31,784
-1.5%
0.28%
+88.6%
Q4 2017$118,805,00032,2840.15%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders